Vujic, I., Sanlorenzo, M., Esteve-Puig, R., Vujic, M., Kwong, A., Tsumura, A., . . . Ortiz-Urda, S. (2016). Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells. Oncotarget.
Citação norma ChicagoVujic, Igor, et al. "Acyl Protein Thioesterase 1 and 2 (APT-1, APT-2) Inhibitors Palmostatin B, ML348 and ML349 Have Different Effects On NRAS Mutant Melanoma Cells." Oncotarget 2016.
ציטוט MLAVujic, Igor, et al. "Acyl Protein Thioesterase 1 and 2 (APT-1, APT-2) Inhibitors Palmostatin B, ML348 and ML349 Have Different Effects On NRAS Mutant Melanoma Cells." Oncotarget 2016.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.